Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Obesogen effect of bisphenol S alters mRNA expression and DNA methylation profiling in male mouse liver. | Chemosphere | 2020 | 31683443 | PubTator, text mining | PubMed |
| Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. | Bone | 2020 | 31655222 | PubTator, text mining | PubMed |
| New candidate genes for ST-elevation myocardial infarction. | J Intern Med | 2020 | 31589004 | PubTator, text mining | PubMed |
| Increased activity of mesenchymal ALK2-BMP signaling causes posteriorly truncated microglossia and disorganization of lingual tissues. | Genesis | 2020 | 31571391 | PubTator, text mining | PubMed |
| Analysis of clinical manifestations and treatment in 26 children with fibrodysplasia ossificans progressiva in China. | World J Pediatr | 2020 | 31529313 | PubTator, text mining | PubMed |
| A Rare Mutation in SMAD9 Associated With High Bone Mass Identifies the SMAD-Dependent BMP Signaling Pathway as a Potential Anabolic Target for Osteoporosis. | J Bone Miner Res | 2020 | 31525280 | PubTator, text mining | PubMed |
| Growth factor and receptor malfunctions associated with human genetic deafness. | Clin Genet | 2020 | 31506927 | PubTator, text mining | PubMed |
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. | SLAS Discov | 2020 | 31498718 | PubTator, text mining | PubMed |
| Reducing INS-IGF1 signaling protects against non-cell autonomous vesicle rupture caused by SNCA spreading. | Autophagy | 2020 | 31354022 | PubTator, text mining | PubMed |
| Recent perspectives of molecular aberrations in pediatric high-grade glioma. | Minerva Pediatr | 2020 | 28643992 | PubTator, text mining | PubMed |
| Sickle cell disease in the era of precision medicine: looking to the future. | Expert Rev Precis Med Drug Dev | 2019 | 33015364 | PubTator, text mining | PubMed |
| Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects. | Neurooncol Adv | 2019 | 32642651 | PubTator, text mining | PubMed |
| The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine. | Genes Dis | 2019 | 32042861 | PubTator, text mining | PubMed |
| MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. | Front Oncol | 2019 | 32039031 | PubTator, text mining | PubMed |
| Effect of black chokeberry on skeletal muscle damage and neuronal cell death. | J Exerc Nutrition Biochem | 2019 | 32018343 | PubTator, text mining | PubMed |
| Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities. | Front Oncol | 2019 | 31998633 | PubTator, text mining | PubMed |
| Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome. | Front Endocrinol (Lausanne) | 2019 | 31998237 | PubTator, text mining | PubMed |
| Scaffold-Based Gene Therapeutics for Osteochondral Tissue Engineering. | Front Pharmacol | 2019 | 31992984 | PubTator, text mining | PubMed |
| SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1. | Hemasphere | 2019 | 31976476 | PubTator, text mining | PubMed |
| Beyond Ruxolitinib: Fedratinib and Other Emergent Treatment Options for Myelofibrosis. | Cancer Manag Res | 2019 | 31920387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=67